The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
248
Perfomance of hrHPV test and cytology
PCK Marine Hospital in Gdynia
Gdynia, Pomeranian Voivodeship, Poland
RECRUITINGAnal intraepithelial neoplasm/ anal cancer
Number of Participants with anal intraepithelial neoplasm/ anal cancer among patients with HPV-related gynecological diseases.
Time frame: Just before surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.